Press Releases
As Rare Disease Drug Approvals Accelerate, PANTHERx® Releases Research on Strengthening Care Coordination
February 25, 2026
Report released for Rare Disease Day shows that while these diseases are rare, the barriers that patients face are unfortunately all too common PITTSBURGH – As the world prepares to mark Rare Disease Day on February 28, the rare disease community faces...
Read MorePANTHERx® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI*
January 8, 2026
PITTSBURGH – PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare disease care and Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases,...
Read MorePANTHERx® Rare Selected by Otsuka America Pharmaceutical, Inc. to Dispense VOYXACT® (sibeprenlimab-szsi) for the Treatment of Primary Immunoglobulin A Nephropathy
December 18, 2025
PITTSBURGH – PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare disease care, announced that it was selected by Otsuka America Pharmaceutical, Inc. (OAPI) as the exclusive specialty pharmacy...
Read MorePANTHERx® Rare Selected by Chiesi for the Distribution of MYCAPSSA®
October 13, 2025
PITTSBURGH – PANTHERx® Rare has been chosen by Chiesi as the exclusive specialty pharmacy to distribute MYCAPSSA® (octreotide). The partnership aims to improve patient access and support for individuals living with acromegaly. MYCAPSSA® is an oral somatostatin...
Read MorePANTHERx® Rare Named the #1 2025 Top Workplace in the Large Employer Category by Pittsburgh Post-Gazette; CEO Recognized with Leadership Award
September 8, 2025
PITTSBURGH – PANTHERx® Rare Pharmacy, a leader in rare disease product patient access and support services in the United States, announced today that it has been recognized as the #1 Top Workplace in the large employer category in Greater Pittsburgh by...
Read MorePANTHERx® Rare Selected by Insmed to Dispense BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
August 13, 2025
PITTSBURGH – PANTHERx® Rare Pharmacy, a leader in rare disease product patient access and support services in the United States, announced that it was selected by Insmed as part of the network of specialty pharmacies to dispense BRINSUPRI™ (brensocatib),...
Read MoreNo posts found